NLRP3 and diabetes mellitus: Collectively, we identified for the first time that alleviation of NLRP3 inflammasome dysregulation and its upstream mechanisms by SG surgery, including ROS overload and chloride efflux, might embrace a rosy future as a promising therapeutic strategy for diabetes mellitus and its related comorbidities.